CHRIS AMOS to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications CHRIS AMOS has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
0.307
-
Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA). Thromb Res. 2023 05; 225:39-46.
Score: 0.111
-
Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors. Transplant Cell Ther. 2021 10; 27(10):864.e1-864.e5.
Score: 0.098
-
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol. 2021 09 01; 96(9):1137-1146.
Score: 0.098